This profile was last updated on .
Is this you? Claim your profile.
300 Pasteur Drive
Stanford Hospital & Clinics is a university-owned, non-profit corporation known for advanced patient care. The 613-bed hospital in Northern California consistently ranks among the top in the nation in surveys by consumers and health professionals. Stanfor...
Find other employees at this company (2,846)
(123 Total References)
Samuel Strober, ...
Samuel Strober, M.D.
Professor of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine
Explore :Research Areas
Samuel Strober, ...
Samuel Strober, M.D.
Scientific Founder and Board Member
Dr. Strober is Professor of Medicine at Stanford University School of Medicine and former Chief of the Division of Immunology and Rheumatology.
He has been President of the Clinical Immunology Society, Chairman of the Board of the La Jolla Institute for Allergy and Immunology and was a scientific founder of Dendreon Corporation.
Dr. Strober's research
has focused on the immune cell interactions that prevent rejection of organ transplants in the absence of immunosuppressive drugs as well as cell interactions that prevent graft versus host disease and retain graft anti-tumor activity after hematopoietic cell transplantation.
Dr. Strober has published over 300 peer-reviewed articles in scientific journals, is the inventor of multiple patented technologies, and has served on editorial boards of immunology journals
He received his B.A. from Columbia University and his M.D. from Harvard University.
Engleman teamed up with fellow ...
Engleman teamed up with fellow Stanford immunologist Samuel Strober to work out ways to make the process more efficient.
When the two pitched their idea for a company to investors, they had little clinical data and were too optimistic about how fast the treatment could reach patients, says Strober
The company was an enormous gamble: harnessing the immune system to fight cancer was still a controversial idea, and no other company had marketed a therapy so personalized and labour-intensive.
"But at that time it was a little different from now," says Strober
"Companies were getting funded on the basis of promise, rather than actually looking at their capacity for early commercial success."
Engleman and Strober founded Dendreon in 1992; the US Food and Drug Administration approved Provenge in 2010.
"We're thinking that this one will progress a lot faster than the Dendreon
thing," says Strober
La Jolla Institute for Allergy & Immunology | Board of Directors
SAMUEL STROBER, M.D.
Professor of Medicine, Division of Immunology and Rheumatology
Stanford University School of Medicine
Dr. Strober has served as Professor of Medicine at Stanford University School of Medicine, Division of Immunology and Rheumatology, since 1982.
He held the position of Chief of that Division from 1978 to 1997, having first arrived at the School of Medicine as a Senior Assistant Resident in 1970.
He has been President of the Clinical Immunology Society, and is a founder of two biotechnology companies (Dendreon, Inc. and Innate Immune, Inc.)
laboratory research and clinical trials have focused on the immune cell interactions that prevent graft versus host disease and retain graft anti-tumor activity after bone marrow transplantation, as well as cell interactions that prevent rejection of organ transplants in the absence of immunosuppressive drugs.
is also interested in the pathogenesis of systemic lupus erythematosus, a disease in which the immune system causes excessive inflammation leading to the damage of multiple organs.
Throughout his career, Dr. Strober has published over 300 peer-reviewed articles in scientific journals, and has served on editorial boards of immunology journals.
received the Leon Reznick Memorial Prize from the Harvard Medical School
Dr. Strober received his B.A. from Columbia University and his M.D. from Harvard University.
completed fellowships in the Surgical Research Laboratory at the Peter Bent Brigham Hospital
in Boston, and in the Sir William Dunn School of Pathology
in Oxford University
followed by an internship in medicine at Massachusetts General Hospital
Prior to joining Stanford, Dr. Strober completed additional postdoctoral training as a Research Associate in the Laboratory of Cell Biology of the National Cancer Institute, Bethesda.
Welcome to LUPUS FOUNDATION of Northern California
Sam Strober, MD 650-723-6500 firstname.lastname@example.org